The table below shows Jazz Pharmaceuticals plc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$1.36B
$1.40B
$1.09B
$1.27B
$778.51M
$899.65M
Capital expenditure
$58.75M
$38.07M
$23.96M
$29.05M
$27.64M
$15.00M
Investing cash flow
-$1.51B
-$508.19M
-$163.06M
-$446.23M
-$5.21B
-$1.01B
Dividends paid
-
-
-
-
-
-
JAZZ operating cash flow (10-K history)
Jazz Pharmaceuticals plc reported operating cash flow of $1.36B for fiscal year 2025. That is down 2.9% from $1.40B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $592.39M (FY 2016) to $1.36B. Figures come from the company's audited annual reports as filed with the SEC.
